Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a pragmatic, quasi-experimental study that tests a structural HIV prevention intervention within law enforcement settings. The SHIELD 2.0 training is delivered with local health workers acting as champions to implement the program. Primary outcomes look at whether police reduce drug-related arrests and increase referrals to MOUD and related health services after the training. The trial combines effectiveness and implementation research to understand how well the program works in real-world police agencies across nine counties in Kentucky. Lead support comes from Johns Hopkins, with collaboration from the University of Kentucky, Northeastern University, and San Diego State University, conducted at the University of Kentucky in Lexington.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* An adult over the age of 18 years old
* Currently employed in a law enforcement agency in one of the nine counties participating in the trial

Exclusion Criteria:

* Only adult participants over the age of 18 will be recruited into the study, and the investigators will not restrict eligibility based on gender, race, or any other socio-demographic characteristics.

Where it's running

• University of Kentucky
  Lexington, Kentucky, United States Recruiting

Study contacts

• Principal investigator: Javier Cepeda, PhD, MPH — Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology
• Study coordinator: Zach R Salazar, MPH
• Email: zachrsalazar@jhu.edu
• Phone: 8132307741

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-acting injectable cabotegravir for preventing HIV in people who inject drugs

  This project tries long-acting injectable cabotegravir plus support services to prevent HIV in adults who inject non-prescription drugs and have sexual exposure risk.

  Recruiting at 2 sites Phase 4 Massachusetts General Hospital · Boston, Massachusetts and 1 other locations · NCT07199335

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Real-time fMRI Neurofeedback for Anhedonia in Methadone-Treated Opioid Use Disorder

  This feasibility study tests a real-time fMRI neurofeedback approach to see if it helps reduce anhedonia in people on methadone for opioid use disorder.

  Recruiting Yale University · New Haven, Connecticut · NCT07768007

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Trauma recovery options for veterans: comparing HRV biofeedback and present-centered therapy

  This trial tests whether Heart Rate Variability Biofeedback plus trauma-informed care helps veterans with PTSD and substance use issues more than present-centered therapy.

  Recruiting Phase 2/3 Coatesville VA Medical Center · Coatesville, Pennsylvania · NCT07756723

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.